199 related articles for article (PubMed ID: 33009019)
21. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
[TBL] [Abstract][Full Text] [Related]
22. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.
Zhou X; Wen W; Shan X; Zhu W; Xu J; Guo R; Cheng W; Wang F; Qi LW; Chen Y; Huang Z; Wang T; Zhu D; Liu P; Shu Y
Oncotarget; 2017 Jan; 8(4):6513-6525. PubMed ID: 28036284
[TBL] [Abstract][Full Text] [Related]
23. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
24. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract][Full Text] [Related]
25. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
[TBL] [Abstract][Full Text] [Related]
27. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma.
Xin Y; Meng K; Guo H; Chen B; Zheng C; Shou X; Yu K
Comb Chem High Throughput Screen; 2022; 25(5):819-830. PubMed ID: 33550967
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W
Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240
[TBL] [Abstract][Full Text] [Related]
29. Identification of key genes and miRNAs markers of papillary thyroid cancer.
Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
[TBL] [Abstract][Full Text] [Related]
30. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
[TBL] [Abstract][Full Text] [Related]
31. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
Yi W; Liu J; Qu S; Fan H; Lv Z
Technol Cancer Res Treat; 2020; 19():1533033820965594. PubMed ID: 33054579
[TBL] [Abstract][Full Text] [Related]
32. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.
Graham ME; Hart RD; Douglas S; Makki FM; Pinto D; Butler AL; Bullock M; Rigby MH; Trites JR; Taylor SM; Singh R
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):33. PubMed ID: 26341226
[TBL] [Abstract][Full Text] [Related]
33. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis of circulating microRNAs in the diagnosis of papillary thyroid carcinoma.
Liu Y; Geng H; Liu X; Cao M; Zhang X
PLoS One; 2021; 16(5):e0251676. PubMed ID: 34019567
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
[TBL] [Abstract][Full Text] [Related]
36. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
37. Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer.
Rogucki M; Sidorkiewicz I; Niemira M; Dzięcioł JB; Buczyńska A; Adamska A; Siewko K; Kościuszko M; Maliszewska K; Wójcicka A; Supronik J; Szelachowska M; Reszeć J; Krętowski AJ; Popławska-Kita A
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681658
[TBL] [Abstract][Full Text] [Related]
38. Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer.
Kondrotienė A; Daukša A; Pamedytytė D; Kazokaitė M; Žvirblienė A; Daukšienė D; Simanavičienė V; Klimaitė R; Golubickaitė I; Stakaitis R; Šarauskas V; Verkauskienė R; Žilaitienė B
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899424
[TBL] [Abstract][Full Text] [Related]
39. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X
Front Genet; 2020; 11():449. PubMed ID: 32508877
[No Abstract] [Full Text] [Related]
40. A panel of microRNA signature in serum for colorectal cancer diagnosis.
Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
